Cargando…
Commentary: Predicting blood concentration of tacrolimus in patients with autoimmune diseases using machine learning techniques based on real-world evidence
Autores principales: | Zhu, Yuxiang, Wang, Xuebin, Wang, Xue, Chen, Lizhi, Wang, Zhuo |
---|---|
Formato: | Online Artículo Texto |
Lenguaje: | English |
Publicado: |
Frontiers Media S.A.
2022
|
Materias: | |
Acceso en línea: | https://www.ncbi.nlm.nih.gov/pmc/articles/PMC9669900/ https://www.ncbi.nlm.nih.gov/pubmed/36408265 http://dx.doi.org/10.3389/fphar.2022.1000476 |
Ejemplares similares
-
Predicting Blood Concentration of Tacrolimus in Patients With Autoimmune Diseases Using Machine Learning Techniques Based on Real-World Evidence
por: Zheng, Ping, et al.
Publicado: (2021) -
Real-world evidence of autoimmune hepatitis following COVID-19 vaccination: A population-based pharmacovigilance analysis
por: Chen, Congqin, et al.
Publicado: (2023) -
The effect of Shengmai injection in patients with coronary heart disease in real world and its personalized medicine research using machine learning techniques
por: Ma, Jing, et al.
Publicado: (2023) -
Plasma metabolomic profiling reveals factors associated with dose-adjusted trough concentration of tacrolimus in liver transplant recipients
por: Zhu, Huaijun, et al.
Publicado: (2022) -
Variation in Tacrolimus Trough Concentrations in Liver Transplant Patients Undergoing Endoscopic Retrograde Cholangiopancreatography: A Retrospective, Observational Study
por: Wang, Rongrong, et al.
Publicado: (2020)